Vaxart Inc ORD (VXRT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO, CA 94080

Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using tablets that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart has believes that its proprietary tablet vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Its development programs currently include tablet vaccines designed to protect against coronavirus, Norovirus, seasonal influenza and respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart's first immuno-oncology indication. Vaxart has filed broad domestic and international patents covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.

Data as of 2021-09-19 12:37:58 -0400
Market Cap1.054 Billion Shares Outstanding125.271 Million Avg 30-day Volume3.511 Million
P/E Ratio-19.48492 Dividend Yield EPS-0.476
Price/Sales850.31 Debt to Equity1.15 EBITDA-49.682 Million
Price to Book Value5.27 Forward PE-0.11 Enterprise Value868.946 Million
Total Cash184.584 Million Current Debt12.78 Million Gross Profit1.239 Million
BETA1.15706 52-week High/Low24.9 / 3.5 Next Earnings Date2021-11-09 Price to Cash FLow (P/CF) -56.8116
Data provided by IEX Cloud
View SEC Filings from VXRT instead.

View recent insider trading info

Funds Holding VXRT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VXRT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FINNEY MICHAEL J.

  • Director
656,090 2021-06-18 2

WILSON KAREN J

  • Director
15,097 2021-06-16 1

DAVIS TODD C

  • Director
15,097 2021-06-16 1

ECHERD MARGARET SVP, PRINCIPAL ACCNTNG OFFICER

  • Officer
100,000 2021-06-16 3

TUCKER SEAN SVP, CHIEF SCIENTIFIC OFFICER

  • Officer
100,000 2021-06-16 2

WHEADON DAVID E.

  • Director
65,700 2021-06-16 2

YEDID ROBERT A.

  • Director
15,097 2021-06-16 2

FLOROIU CEZAR ANDREI PRESIDENT, CHIEF EXEC OFFICER

  • Officer
  • Director
250,000 2021-06-16 1

LATOUR WOUTER

  • Director
1,500,000 2021-05-06 3

ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL MASTER FUND LTD.

BOYD STEVEN

  • Director
291,046 2020-06-26 0

MAHER ILLYA KEITH

  • Director
0 2019-10-25 0

RICHARD JOHN P

  • Director
20,000 2019-10-11 0

COX GEOFFREY F

  • Director
0 2019-06-12 0

VANLENT ANNE

  • Director
0 2019-06-12 0

MARKHAM RICHARD J

  • Director
0 2019-06-12 0

HARLAND JOHN M CHIEF FINANCIAL OFFICER

  • Officer
761 2018-09-11 0

LESCHLY JAN

  • Director
  • 10% Owner
30,793,670 2018-02-13 0

CARE CAPITAL III LLC

CARE CAPITAL INVESTMENTS III L.P.

CARE CAPITAL OFFSHORE INVESTMENTS III LP

  • 10% Owner
30,793,670 2018-02-13 0

LIFE SCIENCE ANGEL INVESTORS III, LLC

  • 10% Owner
0 2018-02-13 0

DOUGHERTY MICHAEL R

  • Director
0 2017-05-18 0

ANIDO ARMANDO

  • Director
0 2017-05-18 0

PLUMB RUSSELL H

  • Director
0 2017-05-18 0

DUNNE MICHAEL W.

  • Director
0 2017-05-18 0

COLONNESE MARK P CHIEF FINANCIAL OFFICER

  • Officer
0 2017-04-03 0

PATTI JOSEPH M CEO

  • Officer
  • Director
0 2017-04-03 0

FOX JAMES

  • Director
2,500 2015-08-11 0

AZZARELLO PETER CHIEF ACCOUNTING OFFICER

  • Officer
0 2015-08-11 0

HILL RICHARD JAMES

  • Director
7,500 2014-05-15 0

ERRINGTON JEFFERY

  • Director
0 2013-05-01 0

COOK PETER CHAPMAN

  • Director
0 2013-05-01 0

GUST IAN D.

  • Director
95,970 2012-11-08 0

BELL PAUL RONALD

  • Director
6,248 2012-11-08 0

KESSLER PAUL D. SVP CLINICAL, MED. & REG.; CMO

  • Officer
105,128 2012-04-05 0

DAVIS PETER B

  • Director
0 2011-05-25 0

CASTALDI DAVID L

  • Director
0 2011-05-25 0

HARVEY RICHARD A JR

  • Director
0 2011-05-25 0

LYNCH TIMOTHY P

  • Director
0 2011-05-25 0

ARYEH JASON

  • Director
0 2011-05-25 0

FAHIM RAAFAT E F PRESIDENT, CEO AND CFO

  • Officer
  • Director
373,474 2011-04-01 0

KALNIK MATTHEW W. SVP STRATEGIC PLAN. & BUS. OPS

  • Officer
71,050 2011-04-01 0

KNOTT DAVID M

  • 10% Owner
No longer subject to file 2009-06-29 0

SUDOVAR STEPHEN

  • Director
0 2009-05-22 0

JENCKES LINDA

  • Director
0 2009-05-22 0

HUDSON LESLIE

  • Director
0 2008-05-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VAXART INC VXRT 2021-09-24 22:15:03 UTC -1.3913 1.4613 600000
VAXART INC VXRT 2021-09-24 21:45:03 UTC -1.391 1.461 600000
VAXART INC VXRT 2021-09-24 21:15:03 UTC -1.391 1.461 600000
VAXART INC VXRT 2021-09-24 20:45:03 UTC -1.3935 1.4635 600000
VAXART INC VXRT 2021-09-24 20:15:03 UTC -1.3935 1.4635 600000
VAXART INC VXRT 2021-09-24 19:45:03 UTC -1.3935 1.4635 600000
VAXART INC VXRT 2021-09-24 19:15:03 UTC -1.3935 1.4635 600000
VAXART INC VXRT 2021-09-24 18:45:03 UTC -1.4424 1.5124 600000
VAXART INC VXRT 2021-09-24 18:15:03 UTC -1.4424 1.5124 600000
VAXART INC VXRT 2021-09-24 17:45:03 UTC -1.4424 1.5124 600000
VAXART INC VXRT 2021-09-24 17:15:03 UTC -1.4424 1.5124 600000
VAXART INC VXRT 2021-09-24 16:45:03 UTC -1.5829 1.6529 600000
VAXART INC VXRT 2021-09-24 16:15:03 UTC -1.5829 1.6529 650000
VAXART INC VXRT 2021-09-24 15:45:03 UTC -1.5829 1.6529 500000
VAXART INC VXRT 2021-09-24 15:15:04 UTC -1.5829 1.6529 200000
VAXART INC VXRT 2021-09-24 14:45:02 UTC -1.4907 1.5607 200000
VAXART INC VXRT 2021-09-24 14:15:02 UTC -1.4907 1.5607 200000
VAXART INC VXRT 2021-09-24 13:45:02 UTC -1.4907 1.5607 200000
VAXART INC VXRT 2021-09-24 13:15:03 UTC -1.4907 1.5607 200000
VAXART INC VXRT 2021-09-24 12:45:03 UTC -1.4907 1.5607 200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund VXRT -15116.0 shares, $-162950.48 2021-04-30 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund VXRT -2317.0 shares, $-17354.33 2021-06-30 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund VXRT -37900.0 shares, $-283871.0 2021-06-30 N-PORT

Elevate your investments